SCHEMBL5184256

SCHEMBL5184256

Cn1nnnc1SCc1cc(C(F)(F)F)ccc1C(=O)Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
LMNA P02545 4/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
HTT P42858 2/20 0.41
S1PR2 O95136 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5182788 0.90 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL5183868 0.87 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL5183398 0.84 MAPT (0.55) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL6847004 0.82 HPD (0.46) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL5182941 0.80 ALOX15 (0.37) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL5183669 0.78 GLA (0.39) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL5183085 0.74 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL5182655 0.72 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP2C19LMNAMAPT
SCHEMBL15033110 0.72 CES2 (0.47) ALDH1A1CYP1A2CYP2C19KDM4EPOLB
SCHEMBL5182688 0.72 MAPT (0.57) ALDH1A1CYP1A2CYP2C19LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1301492-B1 NOVEL TETRAZOLE DERIVATIVES BAYER CROPSCIENCE KK (JP) 2007-07-04 EP disclosed
US-6770599-B2 Tetrazole derivatives BAYER CROPSCIENCE KK (JP) 2004-08-03 US disclosed
US-20030224943-A1 Novel tetrazole derivatives BAYER CROPSCIENCE K. K. (JP) 2003-12-04 US disclosed
EP-1301492-A1 NOVEL TETRAZOLE DERIVATIVES NIHON BAYER AGROCHEM K.K. (JP) 2003-04-16 EP disclosed
WO-2002002536-A1 NOVEL TETRAZOLE DERIVATIVES BAYER CROPSCIENCE K.K. (DE) 2002-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030224943-A1 Novel tetrazole derivatives CBR3, CBR1, ECH1 ALDH1A1 783/4885CYP1A2 220/4885CYP2C19 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.